Introduction
ITRINA-100 is a prescription antifungal capsule containing Itraconazole 100 mg. It is designed for the management of dermatophytosis, onychomycosis, systemic fungal infections, and other challenging mycological conditions.
Composition
Each ITRINA-100 HPMC capsule contains:
| Ingredient | Quantity |
|---|---|
| Itraconazole Pellets eq. to Itraconazole IP | 100 mg |
| Excipients | q.s. |
Pack: 10×10 capsules.
Benefits of ITRINA-100
- Broad-spectrum antifungal activity: Effective against Candida, dermatophytes, and filamentous fungi.
- High clinical potency: Delivers sustained plasma concentration supporting shorter therapy duration in some indications.
- Improves patient compliance: Once-daily dosing regimen in many treatment protocols.
- Suitable for systemic and cutaneous infections: A reliable option when topical therapy is insufficient.
Mechanism of Action
Itraconazole inhibits the fungal cytochrome P450-dependent enzyme lanosterol 14-alpha-demethylase, resulting in ergosterol depletion and disruption of fungal cell membrane synthesis.
Recommended Dosage
- Adults: Typically 100 mg once or twice daily depending on infection type and severity.
- Treatment duration: varies by infection (e.g., 2-6 weeks for dermatophytosis, 3 months or longer for onychomycosis).
- Take with food to enhance absorption.
Precautions
- Contraindicated in patients with hypersensitivity to itraconazole.
- Use with caution in patients with heart failure or hepatic impairment.
- Avoid concurrent use of strong CYP3A4 inhibitors or inducers without physician guidance.
- Monitor liver function periodically during prolonged therapy.
Conclusion
ITRINA-100 capsules are a robust antifungal solution for clinicians seeking effective treatment for both superficial and systemic fungal infections. Use under medical supervision to optimize outcomes and minimize drug interaction risks.